About CMI Indianews
11 February 2000

CMI India Pvt Ltd. is a wholly-owned subsidiary of Centers for Medical Innovation, Germany. Dr Arun Bhatt, formerDr Arun Bhatt, CEO, CMI India medical director of Novartis India, heads the Indian subsidiary.

To begin with, the German parent will invest $10 million in India. The Indian subsidiary will focus on clinical development of plant-based therapies for chronic diseases. Its activities would include plant cultivation, processing, clinical and pre-clinical development, manufacturing, research and development, and distribution.

The company has signed a joint development agreement with Zandu for financing phase 2 and phase 3 clinical trials for HP-200, an anti-Parkinson's drug.

CMI India is also holding talks with the Hyderabad-based Centre for Cellular and Molecular Biology (CCMB) for separate projects.

The Indian subsidiary will also forge development agreements with Indian ayurvedic companies for clinical developments.

also see : List of reports on CMI India

 search domain-b
  go
 
About CMI India